Literature DB >> 8630422

Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria.

M Endo1, R E Ware, T M Vreeke, S P Singh, T A Howard, A Tomita, M H Holguin, C J Parker.   

Abstract

The purpose of these studies was to determine the molecular basis of the phenotypic mosaicism that is a defining feature of paroxysmal nocturnal hemoglobinuria (PNH). Analysis of T cell clones from a female patient revealed four distinct phenotypes based on surface expression of glycosyl phosphatidylinositol-anchored proteins (GPI-AP). When PIG-A (the gene that is mutant in PNH) from these clones was analyzed, four discrete somatic mutations were identified. Analysis of X chromosomal inactivation among the abnormal T cell clones was consistent with polyclonality. Together, these studies demonstrate that the phenotypic mosaicism that is characteristic of PNH is a consequence of genotypic mosaicism and that, at least in this case, PNH is a polyclonal rather than a monoclonal disease. That four distinct somatic mutations were present in a single patient suggests that in conditions that predispose to PNH PIG-A may be hypermutable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630422

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.

Authors:  Tatsuya Kawaguchi; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 2.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

Review 3.  Management issues in paroxysmal nocturnal hemoglobinuria.

Authors:  Gabrielle Meyers; Charles J Parker
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

Review 4.  Molecular genetics of paroxysmal nocturnal hemoglobinuria.

Authors:  Norimitsu Inoue; Yoshiko Murakami; Taroh Kinoshita
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

5.  PIG-A mutations in normal hematopoiesis.

Authors:  Rong Hu; Galina L Mukhina; Steven Piantadosi; Jamie P Barber; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

Review 6.  Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles J Parker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

7.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

8.  The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  David J Araten; Lucio Luzzatto
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

9.  Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria.

Authors:  Michael J Clemente; Bartlomiej Przychodzen; Cassandra M Hirsch; Yasunobu Nagata; Taha Bat; Marcin W Wlodarski; Tomas Radivoyevitch; Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2018-04-25       Impact factor: 11.528

10.  The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.

Authors:  Richard Kelly; Stephen Richards; Peter Hillmen; Anita Hill
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.